Clinical Trials Browser

Terminated × NIH × Muromonab-CD3 × Clear all

NCT00091611 2012-10-26

Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer

Phase 1 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms